We are live on ! Find out more
BIP

Blueprint Investment Partners Portfolio holdings

AUM $1.2B
1-Year Est. Return 35.77%
This Fund
S&P 500
This Quarter Est. Return
-0.14%
1 Year Est. Return
+35.77%
3 Year Est. Return
+90.81%
5 Year Est. Return
+131.4%
10 Year Est. Return
AUM
$200M
AUM Growth
+$75.2M
Cap. Flow
+$78.2M
Cap. Flow %
39.05%
Top 10 Hldgs %
45.8%
Holding
183
New
108
Increased
56
Reduced
14
Closed
3
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDT icon
101
Medtronic
MDT
$114B
$274K 0.14%
+2,188
New +$283K
SBAC icon
102
SBA Communications
SBAC
$19.2B
$272K 0.14%
+823
New +$285K
WELL icon
103
Welltower
WELL
$169B
$272K 0.14%
+3,306
New +$284K
COST icon
104
Costco
COST
$423B
$271K 0.14%
+602
New +$265K
XOM icon
105
ExxonMobil
XOM
$662B
$269K 0.13%
+4,576
New +$261K
LLY icon
106
Eli Lilly
LLY
$1.1T
$266K 0.13%
+1,151
New +$284K
DOC icon
107
Healthpeak Properties
DOC
$14.4B
$260K 0.13%
+7,757
New +$275K
FBNC icon
108
First Bancorp
FBNC
$2.68B
$260K 0.13%
6,034
NEE icon
109
NextEra Energy
NEE
$177B
$255K 0.13%
+3,242
New +$261K
C icon
110
Citigroup
C
$227B
$254K 0.13%
+3,622
New +$253K
AVB icon
111
AvalonBay Communities
AVB
$26.3B
$252K 0.13%
+1,136
New +$255K
DHR icon
112
Danaher
DHR
$147B
$251K 0.13%
+929
New +$253K
RTX icon
113
RTX Corp
RTX
$302B
$250K 0.12%
+2,903
New +$248K
ZTS icon
114
Zoetis
ZTS
$30.9B
$245K 0.12%
+1,261
New +$254K
BMY icon
115
Bristol-Myers Squibb
BMY
$132B
$243K 0.12%
+4,105
New +$270K
UNP icon
116
Union Pacific
UNP
$174B
$242K 0.12%
+1,233
New +$266K
CAT icon
117
Caterpillar
CAT
$385B
$240K 0.12%
1,250
+318
+34% +$66.2K
ORCL icon
118
Oracle
ORCL
$435B
$240K 0.12%
+2,749
New +$243K
PM icon
119
Philip Morris
PM
$290B
$237K 0.12%
+2,497
New +$251K
NVO
120
Novo Nordisk
NVO
$211B
$236K 0.12%
+4,926
New +$238K
QCOM icon
121
Qualcomm
QCOM
$170B
$235K 0.12%
+1,819
New +$258K
EQR icon
122
Equity Residential
EQR
$24.7B
$227K 0.11%
+2,804
New +$232K
LDOS icon
123
Leidos
LDOS
$17.5B
$216K 0.11%
2,250
SBUX icon
124
Starbucks
SBUX
$119B
$214K 0.11%
+1,943
New +$227K
EW icon
125
Edwards Lifesciences
EW
$53B
$213K 0.11%
+1,879
New +$214K

Similar funds

Blueprint Investment Partners's Q3 2021 Portfolio in Review

As of Q3 2021, Blueprint Investment Partners held 183 positions worth $200M, up 60% from $125M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Blueprint Investment Partners deployed $78.2M of net new capital in Q3 2021, opening 108 new positions and adding to 56 existing holdings. Its largest new stake was Vanguard FTSE Developed Markets ETF: 161,808 shares worth $8.17M.

By sector, the portfolio is most concentrated in Technology at 9.5% of assets, up from 5.4% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR Portfolio Developed World ex-US ETF, an estimated $2.03M trimmed.

  • Blueprint Investment Partners's largest Q3 2021 buy was Vanguard FTSE Developed Markets ETF: 161,808 shares worth $8.17M.
  • Blueprint Investment Partners added most to iShares Core MSCI Emerging Markets ETF in Q3 2021, an estimated $4.86M increase.
  • Blueprint Investment Partners's biggest Q3 2021 reduction was State Street SPDR Portfolio Developed World ex-US ETF, cutting an estimated $2.03M.
  • Blueprint Investment Partners fully exited Fidelity Quality Factor ETF in Q3 2021, selling an estimated $6.04M.
  • Blueprint Investment Partners's ten largest holdings make up 46% of its $200M portfolio in Q3 2021.
  • Blueprint Investment Partners opened 108 new positions and closed 3 in Q3 2021.
  • Blueprint Investment Partners's portfolio value rose 60% quarter-over-quarter to $200M.

Based on Blueprint Investment Partners's 13F filing for Q3 2021, filed 4 Nov 2021.